Sujith Kuruvilla1, Rajesh Janardhanan1, Patrick Antkowiak2, Ellen C Keeley1, Nebiyu Adenaw2, Jeremy Brooks2, Frederick H Epstein3, Christopher M Kramer4, Michael Salerno5. 1. Department of Medicine (Cardiology), Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia. 2. Department of Radiology, Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia. 3. Department of Radiology, Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia; Department of Biomedical Engineering, Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia. 4. Department of Medicine (Cardiology), Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia; Department of Radiology, Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia. 5. Department of Medicine (Cardiology), Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia; Department of Radiology, Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia; Department of Biomedical Engineering, Cardiovascular Imaging Center, University of Virginia Health System, Charlottesville, Virginia. Electronic address: ms5pc@virginia.edu.
Abstract
OBJECTIVES: The goal of this study was to assess the relationship among extracellular volume (ECV), native T1, and systolic strain in hypertensive patients with left ventricular hypertrophy (HTN LVH), hypertensive patients without LVH (HTN non-LVH), and normotensive controls. BACKGROUND: Diffuse myocardial fibrosis in HTN LVH patients, as reflected by increased ECV and native T1, may be an underlying mechanism contributing to increased cardiovascular risk compared with HTN non-LVH subjects and controls. Furthermore, increased diffuse fibrosis in HTN LVH subjects may be associated with reduced peak systolic and early diastolic strain rate compared with the other 2 groups. METHODS: T1 mapping was performed in 20 HTN LVH (mean age, 55 ± 11 years), 23 HTN non-LVH (mean age, 61 ± 12 years), and 22 control subjects (mean age, 54 ± 7 years) on a Siemens 1.5-T Avanto (Siemens Healthcare, Erlangen, Germany) using a previously validated modified look-locker inversion-recovery pulse sequence. T1 was measured pre-contrast and 10, 15, and 20 min after injection of 0.15 mmol/kg gadopentetate dimeglumine, and the mean ECV and native T1 were determined for each subject. Measurement of circumferential strain parameters were performed using cine displacement encoding with stimulated echoes. RESULTS: HTN LVH subjects had higher native T1 compared with controls (p < 0.05). HTN LVH subjects had higher ECV compared with HTN non-LVH subjects and controls (p < 0.05). Peak systolic circumferential strain and early diastolic strain rates were reduced in HTN LVH subjects compared with HTN non-LVH subjects and controls (p < 0.05). Increased levels of ECV and native T1 were associated with reduced peak systolic and early diastolic circumferential strain rate across all subjects. CONCLUSIONS: HTN LVH patients had higher ECV, longer native T1 and associated reduction in peak systolic circumferential strain, and early diastolic strain rate compared with HTN non-LVH and control subjects. Measurement of ECV and native T1 provide a noninvasive assessment of diffuse fibrosis in hypertensive heart disease.
OBJECTIVES: The goal of this study was to assess the relationship among extracellular volume (ECV), native T1, and systolic strain in hypertensivepatients with left ventricular hypertrophy (HTN LVH), hypertensivepatients without LVH (HTN non-LVH), and normotensive controls. BACKGROUND: Diffuse myocardial fibrosis in HTN LVH patients, as reflected by increased ECV and native T1, may be an underlying mechanism contributing to increased cardiovascular risk compared with HTN non-LVH subjects and controls. Furthermore, increased diffuse fibrosis in HTN LVH subjects may be associated with reduced peak systolic and early diastolic strain rate compared with the other 2 groups. METHODS: T1 mapping was performed in 20 HTN LVH (mean age, 55 ± 11 years), 23 HTN non-LVH (mean age, 61 ± 12 years), and 22 control subjects (mean age, 54 ± 7 years) on a Siemens 1.5-T Avanto (Siemens Healthcare, Erlangen, Germany) using a previously validated modified look-locker inversion-recovery pulse sequence. T1 was measured pre-contrast and 10, 15, and 20 min after injection of 0.15 mmol/kg gadopentetate dimeglumine, and the mean ECV and native T1 were determined for each subject. Measurement of circumferential strain parameters were performed using cine displacement encoding with stimulated echoes. RESULTS: HTN LVH subjects had higher native T1 compared with controls (p < 0.05). HTN LVH subjects had higher ECV compared with HTN non-LVH subjects and controls (p < 0.05). Peak systolic circumferential strain and early diastolic strain rates were reduced in HTN LVH subjects compared with HTN non-LVH subjects and controls (p < 0.05). Increased levels of ECV and native T1 were associated with reduced peak systolic and early diastolic circumferential strain rate across all subjects. CONCLUSIONS: HTN LVH patients had higher ECV, longer native T1 and associated reduction in peak systolic circumferential strain, and early diastolic strain rate compared with HTN non-LVH and control subjects. Measurement of ECV and native T1 provide a noninvasive assessment of diffuse fibrosis in hypertensive heart disease.
Authors: R J van der Geest; V G Buller; E Jansen; H J Lamb; L H Baur; E E van der Wall; A de Roos; J H Reiber Journal: J Comput Assist Tomogr Date: 1997 Sep-Oct Impact factor: 1.826
Authors: B S Spottiswoode; X Zhong; A T Hess; C M Kramer; E M Meintjes; B M Mayosi; Frederick H Epstein Journal: IEEE Trans Med Imaging Date: 2007-01 Impact factor: 10.048
Authors: Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella Journal: Circulation Date: 2005-02-08 Impact factor: 29.690
Authors: Bruce S Spottiswoode; Xiaodong Zhong; Christine H Lorenz; Bongani M Mayosi; Ernesta M Meintjes; Frederick H Epstein Journal: Med Image Anal Date: 2008-07-09 Impact factor: 8.545
Authors: Iacopo Olivotto; Martin S Maron; Camillo Autore; John R Lesser; Luigi Rega; Giancarlo Casolo; Marcello De Santis; Giovanni Quarta; Stefano Nistri; Franco Cecchi; Carol J Salton; James E Udelson; Warren J Manning; Barry J Maron Journal: J Am Coll Cardiol Date: 2008-08-12 Impact factor: 24.094
Authors: Richard B Thompson; Paolo Raggi; Natasha Wiebe; Martin Ugander; Jannike Nickander; Scott W Klarenbach; Stephanie Thompson; Marcello Tonelli Journal: J Nephrol Date: 2019-02-18 Impact factor: 3.902
Authors: Francesco Sardanelli; Simone Schiaffino; Moreno Zanardo; Francesco Secchi; Paola Maria Cannaò; Federico Ambrogi; Giovanni Di Leo Journal: Eur Radiol Date: 2019-05-02 Impact factor: 5.315
Authors: Fabian aus dem Siepen; Sebastian J Buss; Florian Andre; Sebastian Seitz; Evangelos Giannitsis; Henning Steen; Hugo A Katus; Arnt V Kristen Journal: Clin Res Cardiol Date: 2015-02-18 Impact factor: 5.460
Authors: Adrián I Löffler; Jonathan A Pan; Pelbreton C Balfour; Peter W Shaw; Yang Yang; Moiz Nasir; Daniel A Auger; Frederick H Epstein; Christopher M Kramer; Li-Ming Gan; Michael Salerno Journal: Am J Cardiol Date: 2019-08-22 Impact factor: 2.778